State Street’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $657K | Buy |
+444,239
| New | +$657K | ﹤0.01% | 3567 |
|
|
2024
Q2 | – | Sell |
-826,581
| Closed | -$1.04M | – | 4386 |
|
|
2024
Q1 | $1.04M | Hold |
826,581
| – | – | ﹤0.01% | 3460 |
|
|
2023
Q4 | $1.47M | Buy |
826,581
+66,607
| +9% | +$119K | ﹤0.01% | 3395 |
|
|
2023
Q3 | $1.26M | Buy |
759,974
+28,737
| +4% | +$47.7K | ﹤0.01% | 3465 |
|
|
2023
Q2 | $1.46M | Buy |
+731,237
| New | +$1.46M | ﹤0.01% | 3507 |
|